Anti cancer drug discovery

Anti-cancer drug discovery is the process of identifying and developing drugs that can effectively treat cancer. This process typically involves several stages, including target identification, lead discovery, lead optimization, preclinical testing, and clinical trials.

Target identification involves identifying specific molecules or pathways that play a critical role in the development or progression of cancer. Once a target has been identified, researchers can screen large libraries of compounds to identify potential leads, or drug candidates, that can interact with the target and inhibit its activity.

Lead optimization involves optimizing the properties of a lead compound to improve its potency, selectivity, and pharmacokinetics, or the way the drug is absorbed, distributed, metabolized, and eliminated by the body. Preclinical testing involves testing the drug candidate in laboratory and animal models to evaluate its safety and efficacy before it can be tested in humans.

If the drug candidate shows promising results in preclinical testing, it can then proceed to clinical trials, which involve testing the drug in human volunteers or patients. Clinical trials typically involve three phases, each with increasing numbers of participants, to evaluate the safety, efficacy, and optimal dose of the drug.

Anti-cancer drug discovery is a complex and time-consuming process that can take several years or even decades to complete. However, the development of new cancer drugs has led to significant improvements in the treatment and survival of cancer patients. Advancements in technology, such as high-throughput screening and computational modeling, have helped to accelerate the drug discovery process and improve the success rate of drug development.


    Related Conference of Anti cancer drug discovery

    January 25-26, 2024

    39th World Cardiology Conference

    London, UK
    February 08-09, 2024

    3rd International Conference on Cardiology

    Paris, France
    March 07-08, 2024

    38th World Congress on Heart Diseases

    Toronto, Canada
    March 11-12, 2024

    13th World Heart Congress

    Paris, France
    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France

    Anti cancer drug discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in